A topical peptide that targets CXXC5, a brake on the Wnt pathway that drives hair growth. People apply it to the scalp, often with microneedling and valproic acid, to try to wake dormant follicles in androgenetic hair loss.
We track PTD-DBM across vetted vendors, but none is publicly listing a verifiable price right now. As soon as one does, it shows up here, cheapest first.
No vetted vendor is publicly listing PTD-DBM at a price we can verify yet. We don't show prices we can't stand behind, so this stays empty until one does.
Compare PTD-DBM with other peptides →The simple version first, then a little more for the curious. No biochem degree required.
It releases a brake on the hair-growth pathway. By blocking a protein called CXXC5, it lets Wnt signaling run, which is the signal follicles need to re-enter their growth phase.
PTD-DBM is a Dishevelled-binding motif fused to a protein transduction domain (PTD) that ferries it into cells. Inside, it occupies the spot on Dishevelled where CXXC5 normally docks, so CXXC5 can no longer suppress Wnt/β-catenin signaling, the pathway that drives follicle growth.
It works locally in the scalp skin where it is applied, on the dermal papilla and follicle stem cells. DHT raises CXXC5 in balding scalp, so the idea is to lift that specific brake right where hair is thinning, rather than acting body-wide.
In the research, treated skin showed new hair growth and even new follicles forming in wound-healing models. Users report slow change over months, not weeks, and usually pair it with microneedling for penetration.
Honest caveat: all of the efficacy evidence is from mouse studies out of the Choi lab at Yonsei University. There is no published human randomized trial of PTD-DBM for hair loss as of 2026. It is not an approved medicine and is sold strictly for research use only. None of this is medical advice, talk to a licensed provider before starting anything.
PTD-DBM is applied topically to the scalp, not injected. It comes as a powder you reconstitute into a thin solution and dab onto thinning areas, very often right after microneedling so it can penetrate. The routine is below; for cycling and stacks, see the full guide.
Apply to a clean, dry scalp. Many people microneedle the area first (a 0.5–1.5 mm dermaroller, 1–2 times a week) to open micro-channels that help the peptide reach the follicle.
Reconstituted PTD-DBM is dosed at roughly 0.5–1 mg/mL. Dab or spray a small amount over the thinning area and massage it in lightly. A little goes a long way.
Leave it on. Do not wash the scalp for several hours, ideally apply at night and rinse in the morning. Avoid shampooing right after a microneedling session.
Apply on your weekly schedule and keep going for months. Store the reconstituted vial in the fridge and the sealed powder in the freezer.
Typical PTD-DBM dose: roughly 0.5–1 mg/mL applied topically to the scalp once a week for the first two months, then once every 10 to 15 days through month six. It is run in cycles, usually alongside microneedling and sometimes valproic acid.
How long people run PTD-DBM, when to take a break, and the honest reasoning behind it.
Applied to the scalp weekly, then less often.
A cycle just means a defined run of time on the peptide, followed by a break. For PTD-DBM the common pattern is a roughly six month course, weekly at first then every 10 to 15 days, rather than applying it forever.
Why not just run it indefinitely? Mostly because the long-term human safety data does not exist yet. The cautious and widely followed approach is to run a focused multi-month block, assess, then take a break.
Want the full picture, on and off periods, the washout, stacking, and keeping your results? Read how peptide cycling works →
We haven't yet found a vendor publishing a lab certificate for PTD-DBM that we can link to directly. We don't post purity numbers we can't source. When a vendor publishes a real PTD-DBM COA, it'll show up here.
PTD-DBM is rarely run alone for hair. These are the combinations the community reaches for, all aimed at the same Wnt-driven, follicle-waking goal.
The pairing from the original research. PTD-DBM lifts the CXXC5 brake while valproic acid (a GSK-3β inhibitor) pushes the same Wnt/β-catenin pathway from the other side. Both are applied topically to the scalp.
View stack →A topical hair blend people layer for thinning. GHK-Cu adds copper-peptide support for the scalp and follicle, and Zinc Thymulin is run for its own follicle-signaling angle.
View stack →Not a peptide stack so much as a method. Microneedling 1–2 times a week creates the channels that help PTD-DBM actually reach the dermal papilla, which is where it needs to act.
View stack →Other hair and scalp peptides people compare against PTD-DBM.
PTD-DBM is not an approved drug and is not sold for human use. The vendors we compare offer it strictly for research use only. As an unapproved substance it falls under WADA's S0 category, so competing athletes should steer clear. Rules vary by country, so check what applies where you are.
It means the product is sold for laboratory and research purposes, not as a supplement or medicine for people. It has not been reviewed or approved for human use by the FDA. We aggregate prices and public lab data so you can see the landscape; what you do with that is between you and a licensed provider.
It is a topical, dabbed or sprayed onto a clean scalp over the thinning areas. Microneedling is not strictly required, but most people use a 0.5–1.5 mm dermaroller 1–2 times a week because it opens channels that help the peptide reach the follicle where it needs to act.
Keep the sealed, freeze-dried vial in the freezer and out of light. Once you mix it with bacteriostatic water, store it refrigerated and use it within a few weeks. Do not freeze a reconstituted vial.
Slowly. The research and user reports point to change over months, not weeks, with people often judging it at the three to six month mark. There is no published human trial, so treat any timeline as a rough community estimate rather than a proven result.
This site is for educational and informational purposes only and is not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease, and none of these statements have been evaluated by the FDA or any regulatory authority. Talk to a licensed healthcare provider before starting anything.
Peptides and other compounds referenced on this site are sold by third-party vendors strictly as research chemicals for laboratory and research use only. They are not drugs, dietary supplements, cosmetics, or products intended to diagnose, treat, cure, or be consumed by humans or animals, and nothing here is an offer to sell or any encouragement to use them in any such way. You must be at least 18 years old, and of legal age in your jurisdiction, to use this site. Clearly Peptides does not manufacture, sell, supply, or ship any peptides or compounds.
Lab data, grades, and prices are aggregated from publicly available third-party sources, primarily the Janoshik public database and finnrick, plus community-submitted reports. We don't run labs or test anything ourselves. We present this public information, credit each source, and link back to the original report so you can read it yourself. Listing a vendor or compound is not an endorsement.
Clearly Peptides participates in affiliate programs and may earn a commission when you buy through a link or code on this site, at no extra cost to you.
Clearly Peptides is not liable for any actions you take based on the information provided here. Your use of this site is subject to our Terms of Use.